Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus Test

Primary human papillomavirus (HPV) testing (without concurrent Pap tests) every 3 years is under consideration in the United States as an alternative to the two recommended cervical cancer screening strategies: primary Pap testing every 3 years, or concurrent Pap and HPV testing (“cotesting”) every...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gage, Julia C., Schiffman, Mark, Katki, Hormuzd A., Castle, Philip E., Fetterman, Barbara, Wentzensen, Nicolas, Poitras, Nancy E., Lorey, Thomas, Cheung, Li C., Kinney, Walter K.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2014
Témata:
Brief Communication
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4111283/
https://ncbi.nlm.nih.gov/pubmed/25038467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju153
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky